MedPath

HOSPIRA, INC.

HOSPIRA, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
2004-01-01
Employees
19K
Market Cap
-
Website
http://hospira.com

Clinical Trials

3

Active:2
Completed:1

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

210

FDA:204
PHILIPPINES:6

Drug Approvals

Methotrexate

Approval Date
Aug 22, 2025
FDA

Verapamil Hydrochloride

Approval Date
Aug 18, 2025
FDA

BUPIVACAINE HYDROCHLORIDE

Approval Date
Aug 12, 2025
FDA

Ondansetron

Approval Date
Aug 11, 2025
FDA

Pemetrexed

Approval Date
Jul 30, 2025
FDA

Morphine Sulfate

Approval Date
Jul 30, 2025
FDA

Testosterone Cypionate

Approval Date
Jun 18, 2025
FDA

Testosterone Cypionate

Approval Date
Jun 17, 2025
FDA

Hydromorphone Hydrochloride

Approval Date
May 6, 2025
FDA

Cytarabine

Approval Date
Apr 7, 2025
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)
No trials found

News

Gland Pharma Receives US FDA Approval for Phytonadione Injectable Emulsion

Gland Pharma has secured US FDA approval for its phytonadione injectable emulsion, a generic version of vitamin K1 injectable emulsion.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.